James D. McChesney
Managing Director, Arbor Therapeutics; formerly (1) Chief Scientific Officer, Chromadex; and (2) Professor and Chair of Department of Pharmacognosy, University of Mississippi
Malcolm was lead patent attorney for our European intellectual property whilst I was Chief Scientific Officer of Napro Biotherapeutics, Inc (later renamed Tapestry Pharmaceuticals, Inc). Malcolm was a highly trusted advisor to the Company for the whole period of my office, his expertise relied upon to secure the best possible patent outcomes necessary for a business whose major asset was its IP. Malcolm clearly knew the European IP system and its idiosyncrasies inside out and, with acquired knowledge of the Company’s business, was able to give management timely, lucid advice which it could use to make commercial decisions confidently.
My main personal interactions with Malcolm were naturally at the scientific end of the spectrum, usually in the context of adversarial IP procedures. In picking up an understanding of specialist scientific topics, my experience was that Malcolm achieved rapid comprehension of even difficult science; an hour or two’s discussion would commonly result in Malcolm producing an impressive and persuasive document a few days later which needed little if any technical adaptation from me.
I rate Malcolm very highly in his field at a number of levels.
September 2, 2013 and updated February 21, 2015; James was Malcolm’s client